Drug Combination Details
| General Information of the Combination (ID: C16373) | |||||
|---|---|---|---|---|---|
| Name | Levosimendan NP Info | + | Esmolol Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Cardiogenic shock
[ICD-11: MG40]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Decreasing Adverse Drug Reaction by This Combination | ||||||
| Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vivo Model | A case report | |||||
| Experimental
Result(s) |
levosimendan in combination with a beta-adrenergic antagonist may have beneficial effects in patients with cardiogenic shock who exhibit tachycardia in response to inotropic agents. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists. Br J Anaesth. 2005 Nov;95(5):648-50. | |||
